GL Pharm Tech Corp. (KOSDAQ:204840)
South Korea · Delayed Price · Currency is KRW 1,075.00
+2.00 (0.19%)
At close: Apr 15, 2026
GL Pharm Tech Revenue
In the year 2025, GL Pharm Tech had annual revenue of 35.27B KRW with 35.40% growth. GL Pharm Tech had revenue of 9.53B in the quarter ending December 31, 2025, with 11.31% growth.
Revenue
35.27B
Revenue Growth
+35.40%
P/S Ratio
2.36
Revenue / Employee
1.07B
Employees
33
Market Cap
83.37B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 35.27B | 9.22B | 35.40% |
| Dec 31, 2024 | 26.05B | 14.93M | 0.06% |
| Dec 31, 2023 | 26.03B | 9.30B | 55.62% |
| Dec 31, 2022 | 16.73B | 4.30B | 34.63% |
| Dec 31, 2021 | 12.43B | 437.53M | 3.65% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Ahn-Gook Pharmaceutical | 306.87B |
| Cosmax Nbt | 287.48B |
| H.PIO | 258.19B |
| Sinsin Pharmaceutical | 113.78B |
| Hwail Pharmaceutical | 107.87B |
| Sinil Pharmaceutical | 80.56B |
| Sam-A Pharm. | 77.80B |
| Polaris AI Pharma | 63.94B |